Luiz Belardinelli

Director Técnico/Científico/I+D en InCarda Therapeutics, Inc. .

Health Technology

Perfil

Luiz Belardinelli is currently the Chief Medical Officer at InCarda Therapeutics, Inc. He previously worked as the Senior Vice President-Pharmacology at CV Therapeutics, Inc.

Cargos activos de Luiz Belardinelli

Empresas	Cargo	Inicio
InCarda Therapeutics, Inc. InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA.	Director Técnico/Científico/I+D	05/04/2016

Todos los cargos activos de Luiz Belardinelli

Antiguos cargos conocidos de Luiz Belardinelli.

Empresas	Cargo	Fin
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Corporate Officer/Principal	02/05/2011

Ver el detalle de la experiencia de Luiz Belardinelli.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Luiz Belardinelli.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology
InCarda Therapeutics, Inc. InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA.	Health Technology